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Abstract:  Asthma is a Th2-dependent disease mediated by IgE and Th2 cytokines, and asthmatic patients suffer from oxidative 
stresses from abnormal airway inflammation. Vitamin C is a micro-nutrient functioning as an antioxidant. When administered 
at a mega-dose, vitamin C has been reported to shift immune responses toward Th1. Thus, we tried to determine whether 
vitamin C exerted beneficial effects in asthma animal model. Asthma was induced in mice by sensitizing and challenging with 
ovalbumin. At the time of challenge, 3~5 mg of vitamin C was administered and the effects were evaluated. Vitamin C did 
not modulate Th1/Th2 balance in asthma model. However, it decreased airway hyperreactivity to methacholine, decreased 
inflammatory cell numbers in brochoalveolar lavage fluid, and moderate reduction of perivascular and peribronchiolar 
inflammatory cell infiltration. These results suggest that vitamin C administered at the time of antigen challenge exerted anti-
inflammatory effects. Further studies based on chronic asthma model are needed to evaluate a long-term effect of vitamin C 
in asthma. In conclusion, even though vitamin C did not show any Th1/Th2 shifting effects in this experiment, it still exerted 
moderate anti-inflammatory effects. Considering other beneficial effects and inexpensiveness of vitamin C, mega-dose usage of 
vitamin C could be a potential supplementary modality for the management of asthma. 
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prevalence of asthma is increasing over and over worldwide, 
and in addition, it is sometimes refractory to conventional 
treatment (Chanez et al., 2007). 
Because it is well established that asthmatic patients suffer 
from oxidative stresses from abnormal airway inflammation 
(Kelly et al., 1999; Schock et al., 2003), a lot of studies have 
been devoted to elucidating the relationship between dietary 
intake and serum level of antioxidants and the prevalence and 
severity of the disease (Gao et al., 2008; Sackesen et al., 2008). 
One of the most probably associated dietary antioxidants with 
asthma is vitamin C (Harik-Khan et al., 2004). 
Vitamin C is an essential micro-nutrient involved in 
several metabolic pathways (Naidu 2003) and is regarded 
as an important physiological antioxidant (Guaiquil et al., 
2001). Most mammals produce vitamin C by themselves, 
while some mammals including men, some primates, and 
guinea pig do not. Thus, men have to be supplemented with 
exogenous vitamin C by taking fresh fruits and vegetables, 
Introduction
Allergic asthma is a chronic obstructive inflammatory lung 
disease characterized by increased reactivity of airway smooth 
muscles and remodeling of airway tracts. Traditionally, 
asthma is thought to be a Th2-dependent disease and is 
known to be mediated by elevated serum IgE levels (Barrios 
et al., 2006). Th2 cytokines such as IL-4, IL-5, IL-9, and IL-
13 play major roles in the initiation and perpetuation of the 
disease (Barrios et al., 2006; Tulic & Hamid, 2006; Doherty 
& Broide, 2007), although TNF-alpha, the Th1 cytokine, is 
also a critical factor in severe cases (Holgate et al., 2006). The Attenuation of lung inflammation by mega-dose vitamin C
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and/or supplementary pills. It is well known that the deficit of 
vitamin C lead to the scurby (Naidu 2003). 
Vitamin C is also known to modulate immune responses. 
Recently, it has been reported that mega-dose vitamin C 
administered in mice shifted immune responses toward Th1 
with suppression of Th2 responses (Noh et al., 2003; Noh et 
al., 2005). Conversely, inadequate vitamin C supplementation 
in L-gulono-γ-lactone oxidase deficient mice which can not 
synthesize vitamin C by themselves (Maeda et al., 2000) 
resulted in a decreased Th1 response against H. pylri infection 
(Lee et al., 2008). 
Considering the pathophysiology of asthma, vitamin 
C could be used for the treatment and/or management of 
asthma as an antioxidant and/or as a Th1-shifting agent. 
Actually, studies on the beneficial effects of high dose vitamin 
C intake in asthmatic patients have been performed by some 
authors. However, the effects are still in controversy (Fogarty 
et al., 2003; Fogarty et al., 2006; Tecklenburg et al., 2007; Kaur 
et al., 2009). This controversy might come from differences 
in experimental settings such as criteria for patient selection, 
recommended dosage of vitamin C, parameters measured, 
and so on. 
In this study, we tried to determine the effect of vitamin 
C on asthma in an experimental animal model. Our results 
showed that vitamin C did not changed Th1/Th2 balance in 
asthma. However, it exerted some anti-inflammatory effects 
against lung inflammation. 
Materials and Methods 
Experimental animals 
Eight week-old male Balb/c mice were purchased from 
BioLink (Seoul, Korea) and kept under 12 h dark and light 
cycle in the Animal Facility of our Institute. Food and water 
were given ad libitum. Animal experiments were permitted by 
the Institute of Laboratory Animal Resources Seoul National 
University (permission number SNU-060920-5), and all the 
animal experimental procedures were performed following 
the SOP of our Institute. 
Induction of experimental asthma model 
Mice were sensitized on 3 consecutive days by intra-
peritoneal injection of 100 μg ovalbumin (OVA; Sigma, St. 
Louis, MO) immersed in a same volume of alum (Peirce, 
Rock  ford, IL). On days 18, 19, 22, and 23, mice were 
challenged with intranasal dripping of 25 μg OVA/30 μl PBS. 
On days from 18 to 24, mice were given an intraperitoneal 
injection of either 3 or 5 mg vitamin C dissolved in 100 μl 
PBS or of a same volume of PBS. Each experimental group 
consisted of 8 mice. On day 24, plethysmography was done. 
All experiments were repeated 3 times. 
Airway hyperresponsiveness (AHR) 
AHR was assessed indirectly by measuring methacholine-
induced airway obstruction. Mice were challenged with 
serially increasing concentrations of nebulized methacholine 
(Sigma, St. Louis, MO) in a range of 0~50 mg/ml for 3 
min and were placed in a whole body plethysmography 
chamber (Allmedicus Co., Ltd, Model # OCP-3000) after 
each concentration of methacholine exposure. Breathing 
pattern was recorded for 2 min and enhanced pause (Penh) 
was calculated using a software program based on measured 
parameters such as expiratory time, relaxation time, peak 
expiratory flow, and peak inspiratory flow.
Bronchoalveolar lavage and tissue processing 
Mice were sacrificed on day 25 by deep anesthesia. After 
anesthesia, blood was drawn from orbital plexus and serum 
was obtained after clotting in a refrigerator. Bronchoalveolar 
lavage fluid (BALF) and lung tissue were obtained 
immediately after sacrifice. BAL was done with 1 ml of saline. 
Obtained fluids were centrifuged (4,000 rpm, 10 min) to get 
sedimented cells and supernatants. Cells were resuspended 
in 300 μl PBS and were used for cell count and for monolayer 
cell spread by cytospin (Shandon Cytospin 2) (800 rpm, 
10 min). Spread cells were stained with Wright`s staining 
solution (Sigma, St. Louis, MO) and used for differential cell 
counts. Supernatnats were kept frozen until use for cytokine 
ELISA (Biosource, Camarillo, CA). 
After BAL, lungs were inflamed with 1 ml Bouin's solution 
and further fixed in the same solution for 24 h. Routine 
processes for paraffin embedding were carried out, and 6 
μm-thick paraffin sections were made. Tissue sections were 
subjected to hematoxylin and eosin staining for routine 
microscopic observation, and to periodic acid-Schiff's 
staining for goblet cell observation in the airway epithelium. 
Histopathological scoring of lung tissues 
The intensity of peribronchial and perivascular 
inflammatory cell infiltration was scored as the approximate 
number of layers of cells around vessels or bronchiols. In Anat Cell Biol 43:294~302, 2010 Young-Joo Jeong, et al 296
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a tissue section, the intensity of infiltration varied for each 
vessel and airway, and thus the most severely infiltrated one 
was regarded as a representative one for the section. The 
degree of goblet cell hyperplasia was evaluated as the ratio 
of respiratory epithelium composed of PAS-positive goblet 
cells to the total epithelium. To get the ratio, the length of 
all the respiratory tracts shown in the section was measured 
and summed with respect to normal or PAS positive area. 
Measurement was done using image analysis software 
RHINOCEROS 4.0 program. 
ELISA for serum antigen-specific antibody titration 
Titers of OVA-specific antibodies in the serum were 
determined as follows. Ninety six-well plates (Nunc, 
Rochester, NY) were coated with 100 μl of 3 μg/ml OVA/well 
at 4
oC overnight. Plates were then briefly washed and blocked 
with 1% skim milk in PBS for 1 h at room temperature. One 
hundred-fold diluted serum samples were applied to the 
first row of a plate and 4-fold serial dilution was done. All 
samples were duplicated. After 2 hour-incubation at room 
temperature, plates were washed with a PBS-0.05% Tween 20 
mixture, and alkaline phosphatase-conjugated antibodies for 
each isotype were added. After incubation for 60 min at room 
temperature, plates were washed and p-nitrophenyl phosphate 
substrate (Amresco, Solon, OH) solution was added. OD 
values were measured at 405 nm. The antibodies used were 
as follows; goat anti-mouse polyvalent immunoglobulins (1 
: 1,000 diluted, Sigma), goat anti-mouse IgM, IgG1, IgG2a, 
IgG2b, IgG3, and IgE antibodies (1 : 1,000 diluted, Southern 
Biotech, Birmingham, AL). OVA-specific anti-sera obtained 
from previous experiments were collected in a tube and 
used as a standard serum in every ELISA plate. Titers were 
expressed as a relative value to the standard serum value. 
Statistical analysis 
Statistical analysis was performed by Student's t test or 
Wilcoxon rank sum test. Statistical significance was set at P< 
0.05. 
Results 
Vitamin C administered during challenge reduced 
airway resistance induced by methacholine
Airway resistance induced by methacholine inhalation was 
evaluated by plethysmography (Fig. 1). Airway resistances 
in PBS-injected asthma group were significantly higher with 
all concentrations of methacholine (P<0.05) compared to 
those of normal control group. In contrast, vitamin C-treated 
asthma group showed similar resistances to those of normal 
control group with 6.25, 12.5, 25 mg/ml of methacholine. 
However, resistance with 50 mg/ml of methacholine was 
elevated compared to normal control group, which was still 
lower than that of PBS-injected asthma group. These results 
indicate that vitamin C administered during antigen challenge 
reduced AHR. 
Vitamin C treatment reduced the number of 
inflammatory cells in bronchoalveolar lavage fluid
To approximate the extent of inflammation in each group, 
total numbers of inflammatory cells in bronchoalveolar lavage 
fluid (BALF) were counted. The numbers were standardized 
to the volume of fluid re-collected and depicted in Fig. 2 (left 
panel). In normal control group, BALF cells were scanty, 
while cell numbers substantially increased both in PBS-
injected and vitamin C-treated asthma groups. Of note is that 
the number of cells from vitamin C-treated group was lower 
than that from PBS-injected group with statistical significance 
(P<0.05). To investigate the composition of BALF cells, they 
were spread on a glass slide, stained with Wright’s solution, 
Fig. 1. Plethysmography of normal and asthma-induced mice. Mice 
were inhaled with aerosol containing methacholine at concentrations 
indicated and placed in the plethymography chamber. Breathing was 
recorded for 2 min and airway resistance was calculated thereby. PBS-
treated mice with asthma (■) showed increased airway resistance 
compared to normal mice (◆) at all concentrations of methacholine. 
Meanwhile, vitamin C-treated mice with asthma (▲) showed decreased 
resistance than that of PBS-injected mice, and that was similar to that 
of normal mice at methacholline concentrations from 6.25 to 25 mg/
ml. *P<0.05.Attenuation of lung inflammation by mega-dose vitamin C
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and the numbers of each immune cell including neutrophils, 
eosinophils, lymphocytes, and macrophage were differentially 
counted under light microscope. Majority of the cells from 
normal mice were macrophages (Fig. 3, left panels). In 
experimental groups, BALF cells were mainly composed of 
macrophages and eosinophils (middle and right panels in Fig. 
3), which comprised 33.6% and 63.1%, and 20.2% and 65.4% 
of total cells in PBS-treated and vitamin C-treated groups 
respectively (Fig. 2, right panel). Occasional lymphocytes and 
neutrophils were also observed with a low frequency (2.9% 
and 0.4% in PBS-treated group, 3.7% and 0.7% in vitamin 
C-treated group). This compositional difference of cells 
between these two groups was statistically insignificant (P> 
0.05). Thus, vitamin C reduced total cell numbers in BALF, 
however, it did not affect the ratio of immune cells in BALF. 
Another finding that was observed was that macrophages 
from asthmatic mice revealed an activated appearance with 
a euchromatic nucleus, enlarged cell size, and cytoplasmic 
phagocytic vacuoles, while those from normal control mice 
showed quiescent appearance (lower panels in Fig. 3). 
Vitamin C lowered the intensity of inflammatory cell 
infiltration around vessels and airways
One of the histological hallmarks of lung inflammation 
accompanying asthma is cellular infiltration around 
blood vessels and airway tracts (Duan et al., 2004). To 
evaluate whether vitamin C treatment during asthma 
induction affected perivascular and/or peribronchiolar 
cell infiltration, histological examination was performed. 
Lung tissues from normal mice showed no perivascular nor 
peribronchiolar inflammatory cell infiltration at all (Figs. 
4A and D). Meanwhile, asthma induction resulted in cell 
infiltration around blood vessels and airway tracts. The cell 
infiltration was more prominent around blood vessels than 
around airways. The thickness of cell infiltration was semi-
quantitatively evaluated by counting cell layers around the 
vessels or airways. As results, PBS-injected group showed 
perivascular infiltration of 6.4±1.5 cell layer-thick in average, 
which was thicker than that for vitamin C-treated group 
(5.0±2.9). This difference was statistically significant (P<0.05). 
The intensity of peribronchiloar cell infiltration also showed a 
tendency of reduction in vitamin C-treated group compared 
to PBS-injected group with average values of 1.2±0.9 and 
2.6±1.8, respectively (P=0.058). 
One of the characteristic changes following asthma 
induction is mucus hyperplasia of respiratory epithelium 
(Izuhara et al., 2009). Thus, we evaluated whether vitamin C 
treatment affected mucus hyperplasia. Lung tissues were PAS-
stained and the degree of mucus hyperplasia was evaluated 
as the ratio of mucus-containing PAS-positive goblet cells 
per total respiratory epithelium (Figs. 4G~I). In normal 
mice, PAS-positive cells were hardly observed in the airway 
Fig. 2. (left panel) Cell numbers in BALF. Mice were anesthesized and 1 ml of saline was infused into the lung through a needle in the trachea. 
The fluid was re-drawn after 1 min and centrifuged. Obtained cells were re-suspended, and cell count was done. Scanty cells were found in BALF 
from normal mice while many inflammatory cells were observed in BALF from asthma-induce mice. Vitamin C-treated mice showed less number 
of BALF cells than PBS-injected mice. A representative profile of three independent experiments. n=8 for each group. *P<0.05. (right panel) 
Differential cell counts of BALF cells from asthmatic mice. Cells were spread on a glass slide, stained with Wright’s solution, and differentially 
counted under light microscope. In both experimental groups, eosinophils comprised about two thirds of total cells, and the other one third was 
almost macrophages. Lymphocytes and neutrophils were observerd with a very low frequency. These two groups showed no difference in cellular 
composition of BALF (P>0.05). Over 1,000 cells were counted in each group.Anat Cell Biol 43:294~302, 2010 Young-Joo Jeong, et al 298
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Fig. 3. Wright staining of BALF cells. After centrifugation of BALF, sedimented cells were re-suspended in 300 μl PBS containing 0.05% albumin and monolayer 
cell spread was prepared by cytospin. In normal mice, cells were scanty and almost all cells were macrophages with a quiescent appearance (left panels). Cells from 
mice with asthma, irrespective of PBS (middle panels) or vitamin C treatment (right panels), were abundant in number and mostly composed of eosinophils 
and macrophages. Macrophages in these groups differed from those of normal mice in their appearance and size. ×100 magnification (upper panels) and ×800 
magnification (lower panels). 
Fig. 4. Histological scoring of lung tissue. Paraffin sections were stained with hematoxylin and eosin (A~F) or with periodic acid-Schiff's reagent (G~I). The 
intensity of perivascular inflammatory cell infiltration (upper panels) or of peribronchiolr infiltration (middle panels) were semi-quantified as the numbers of cell 
layers and were depicted in graphs on the right column. Mucus hyperplasia were quantified as the ratio that goblet cells occupied on the respiratory epithelium 
and also depicted in the graph on the right column. Vitamin C administration significantly decreased the perivascular cell infiltration and tended to decrease 
peribronchiloar cell infiltration. However, the intensity of mucus hyperplasia was not affected by vitamin C treatment. Attenuation of lung inflammation by mega-dose vitamin C
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did not show any differences in both groups (data not shown). 
Discussion 
The aim of this study was to determine whether vitamin C 
administration did a beneficial role in animal asthma model. 
As results, vitamin C administered at a high dose at the time 
of antigen challenge reduced airway resistance provoked by 
methacholine. In addition, vitamin C reduced not only the 
number of inflammatory cells in BALF, but perivascular and 
peribronchilar inflammatory cell infiltration. All these results 
together suggest that vitamin C attenuated lung inflammation 
induced by asthma. 
Asthma has been regarded as a Th2-dependent disease, 
and Th2 cytokines such as IL-4, IL-5, and IL-13 with TGFβ 
predispose and maintain this disease (Tagaya & Tamaoki, 
2007; Broide 2008). Because a mega-dose vitamin C 
administered into the body shifts immune responses towards 
Th1 (Noh et al., 2003; Noh et al., 2005), we expected vitamin 
C administration at the time of antigen challenge in asthma 
epithelium from trachea to terminal bronchiole (Fig. 4G). In 
experimental animals, epithelia of airways, especially those 
of large ones, were covered by PAS-positive mucus secreting 
cells. In PBS-injected mice, goblet cells covered 25.7±15.3% 
of all the respiratory epithelia in average, which was at a 
similar level to that for vitamin C-treated group (28.5±14.8%). 
Thus, it looks like that vitamin C given at the time of antigen 
challenge did not affect mucus hyperplasia. 
Vitamin C did not shift immune responses with 
regard to Th1/Th2
Ovalbumin-specific serum antibody titers for each isotype 
were measured (Fig. 5) to determine whether vitamin C 
shifted immune responses toward Th1 in asthma animal 
model. Results showed that OVA-specific antibody titers were 
not different in the two experimental groups in both Th1-
dependent isotypes (IgG1 and IgE) and a Th2-dependent 
isotype (IgG2a). In addition, when the secretion of Th1 
cytokines such as IL-12, IFN-γ, and TNF-α and Th2 cytokines 
such as IL-4 and IL-5 in the BAL fluid were measured, they 
Fig. 5. OVA-specific serum antibody titers after asthma induction. 
Mice were sensitized on days 1, 2, and 3 by peritoneal injection of 100 
μg ovalbumin immersed in alum and challenged on days 18, 19, 22, and 
23, by intranasal dripping of 25 μg OVA/30 μl PBS. On day 25, blood 
samples were drawn from orbital venous plexus. Sera were obtained and 
OVA-specific ELISA titrations were performed for each isotype. Both 
the PBS-injected and vitamin C-treated mice showed elevated levels of 
antigen-specific titers in all isotypes. However, there was no statistically 
significant differences in the titers between these two groups. A 
representative profile of three independent experiments. n=8 for each 
group. Anat Cell Biol 43:294~302, 2010 Young-Joo Jeong, et al 300
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model would attenuate the disease by shifting immune 
response toward Th1. Actually, this idea has been mentioned 
by some authors. A high dose vitamin C administration 
was recently reported to decrease eosinophilic infiltration 
in ovalbumin-induced asthma mouse model (Chang et al., 
2009) and to decrease inflammatory cells in BALF, not only 
eosinophils but also neutrophils and lympocytes in asthmatic 
guinea pig model (Haines et al., 2010). In line with this 
concept, treatment using anti-cytokine agents or bacterial 
components aiming at the change of Th1/Th2 balance have 
been tired in moderate and severe asthmatics (Bjermer & 
Diamant 2004; Desai & Brightling, 2009). However, against 
the expectation, the results obtained in this experiment do 
not support Th1-shifting effects of vitamin C in asthma 
animal model. Vitamin C treatment did not shifted antigen-
specific serum antibody isotype toward Th1 profile, neither 
changed cytokine profiles in BALF with respect to Th1/Th2 
responses. In addition, cells in BALF from vitamin C-treated 
mice were composed mainly of macrophages and eosinophils 
just like in PBS-injected group. If Th1 shifting had been 
occurred by vitamin C administration, neutrophils were 
expected to prevail (Cohn et al., 1998). Vitamin C given at 
the time of sensitization did not affected Th1/Th2 balance 
either. When we treated mice with vitamin C for 10 days 
during which mice were intraperitoneally sensitized with 
OVA, it exerted absolutely no effects on asthma including 
Penh, BALF cell number, and lung inflammation (unpublished 
data). These results are against what previously reported with 
delayed type hypersensitivity reaction induced by keyhole 
lympet hemocyanin (Noh et al., 2005). In that experiment, 
administered mega-dose vitamin C clearly shifted immune 
responses toward Th1, nearly completely suppressing serum 
antigen-specific IgG1 and IgE antibody titers and rendering 
splenic T cells to secrete more IL-4 and less IFN-γ. We have 
no data to explain what made this discrepancy at this time. 
However, it has been reported that the immune response in 
animal asthma model varied depending on the route and 
frequency of antigen administration (Nelde et al., 2001). 
Another possible clue to explain the discrepancy is that 
dendritic cells, which play an initial and principal role in Th1/
Th2 shaping, have many subtypes which lodge differently 
from location to location in the body. These subtypes of 
dendritic cells respond differentially to a same antigen in 
different ways (Kirby et al., 2001; Marleau et al., 2008). That 
might direct immune responses against a same antigen 
differently according to the route through which antigens 
enter the body. This point need to be further elucidated. 
Even though no evidence of Th1 shifting was observed 
in this experiment, it is still true that the administered 
vitamin C attenuated the intensity of lung inflammation as 
evidenced by decreased cell numbers in BALF and less severe 
perivascular and peribronchial cell infiltration. These effects 
seems to be attributed to anti-inflammatory effects of vitamin 
C. Serum concentration of vitamin C has been supposed to 
be associated with inflammation in several epidemiological 
studies (Langlois et al., 2001; Wannamethee et al., 2006; Rizzo 
et al., 2008). In addition, anti-inflammatory effect of vitamin 
C has been clinically applied to pancreatitis (Du et al., 2003) 
with modest attenuation of serum inflammatory markers. 
These anti-inflammatory effects of vitamin C were ascribed to 
the anti-oxidant property of it. Or, some investigators insisted 
that vitamin C directly inhibited IkB kinase phosphorylation 
leading to eventual inhibition of NF-kB activation, which 
plays a critical role in inflammation (Cárcamo et al., 2002). 
However, this anti-inflammatory effect has been denied 
by some authors (Scott et al., 2005; Hernandez et al., 2009; 
Kamgar et al., 2009). Thus, there are some controversies 
whether vitamin C is beneficial to inflammation. Our results 
support anti-inflammatory effects of vitamin C. That is, 
vitamin C given at the time of antigen challenge attenuated 
AHR and lung inflammation. However, the effect was 
not so much distinguished. Asthma is in nature a chronic 
inflammatory disease characterized by a phenominon known 
as "airway remodelling", which is contributed by subepithelial 
basement membrane thickening and fibrosis, increased 
smooth muscle cells, hyperplasia of mucus-secreting goblet 
cells, and so on (Hamid & Tulic, 2009). These changes takes 
time to occur and animal model of asthma usually does not 
reflect these changes satisfactorily because the disease model 
is not a chronic one (McMillan & Lloyd, 2004). Our model 
was also an acute one, and it should be necessary to evaluate 
the effects of vitamin C on the remodelling of airways in an 
established chronic type of asthma model (Zhou et al., 2008). 
In conclusion, even though vitamin C did not show any 
Th1/Th2 shifting effects in this experiment, it still exerted 
moderate anti-inflammatory effects. Furthermore, we can 
not still rule out that chronic usage of vitamin C would 
exert more beneficial effects on asthma. Considering other 
beneficial effects and that vitamin C is not an expensive one, 
we can regard mega-dose usage of vitamin C as a potential 
supplementary modality for the management of asthma. Attenuation of lung inflammation by mega-dose vitamin C
doi: 10.5115/acb.2010.43.4.294
Anat Cell Biol 43:294~302, 2010 301
www.acbjournal.com
www.acbjournal.org
C inhibition of cell death induced by oxidative stress in 
glutathione-depleted HL-60 cells. J Biol Chem 276: 40955-40961
Haines DD, Varga B, Bak I, et al. (2010). Summative interac-
tion between astaxanthin, Ginkgo biloba extract (EGb761) 
and vitamin C in Suppression of respiratory inflammation: 
a comparison with ibuprofen. Phytother Res [Epub ahead of   
Print]
Hamid Q, Tulic M. (2009). Immunobiology of asthma. Annu Rev 
Physiol 71: 489-507
Harik-Khan RI, Muller DC, Wise RA. (2004). Serum vitamin levels 
and the risk of asthma in children. Am J Epidemiol 159: 351-357
Hernandez M, Zhou H, Zhou B, et al. (2009). Combination 
treatment with high-dose vitamin C and alpha-tocopherol does 
not enhance respiratory-tract lining fluid vitamin C levels in 
asthmatics. Inhal Toxicol 21: 173-181
 Holgate ST, Holloway J, Wilson S, et al. (2006). Understanding the 
pathophysiology of severe asthma to generate new therapeutic 
opportunities. J Allergy Clin Immunol 117: 496-506
Izuhara K, Ohta S, Shiraishi H, et al. (2009). The mechanism of 
mucus production in bronchial asthma. Curr Med Chem 16: 
2867-2875
Kamgar M, Zaldivar F, Vaziri ND, Pahl MV. (2009). Antioxidant 
therapy does not ameliorate oxidative stress and inflammation in 
patients with end-stage renal disease. J Natl Med Assoc 101: 336-
344
Kaur B, Rowe BH, Arnold E. (2009). Vitamin C supple  mentation for 
asthma. Cochrane Database Syst Rev (1): CD000993
 Kelly FJ, Mudway I, Blomberg A, Frew A, Sandström T. (1999). 
Altered lung antioxidant status in patients with mild asthma. 
Lancet 354: 482-483
Kirby AC, Yrlid U, Svensson M, Wick MJ. (2001). Differential 
involvement of dendritic cell subsets during acute Salmonella 
infection. J Immunol 166: 6802-6811
Langlois M, Duprez D, Delanghe J, De Buyzere M, Clement DL. 
(2001). Serum vitamin C concentration is low in peripheral 
arterial disease and is associated with inflammation and severity 
of atherosclerosis. Circulation 103: 1863-1868
Lee CW, Wang XD, Chien KL, et al. (2008). Vitamin C 
supplementation does not protect L-gulono-gamma-lactone 
oxidase-deficient mice from Helicobacter pylori-induced 
gastritis and gastric premalignancy. Int J Cancer 122: 1068-1076
Maeda N, Hagihara H, Nakata Y, Hiller S, Wilder J, Reddick R. (2000). 
Aortic wall damage in mice unable to synthesize ascorbic acid. 
Proc Natl Acad Sci U S A 97: 841-846
Marleau AM, Summers KL, Singh B. (2008). Differential 
contributions of APC subsets to T cell activation in nonobese 
diabetic mice. J Immunol 180: 5235-5249
McMillan SJ, Lloyd CM. (2004). Prolonged allergen challenge in 
mice leads to persistent airway remodelling. Clin Exp Allergy 34: 
497-507
Naidu KA. (2003). Vitamin C in human health and disease is still a 
mystery? An overview. Nutr J 2: 7
 Nelde A, Teufel M, Hahn C, et al. (2001). The impact of the route 
and frequency of antigen exposure on the IgE response in 
Acknowledgements
This work was supported by grant number 04-2007-0900 
from the SNUH research fund.
References
Barrios RJ, Kheradmand F, Batts L, Corry DB. (2006). Asthma: 
pathology and pathophysiology. Arch Pathol Lab Med 130: 447-
451
Bjermer L, Diamant Z. (2004). Current and emerging nonsteroidal 
anti-inflammatory therapies targeting spe  cific mechanisms in 
asthma and allergy. Treat Respir Med 3: 235-246
Broide DH. (2008). Immunologic and inflammatory mechanisms 
that drive asthma progression to remodeling. J Allergy Clin 
Immunol 121: 560-570
Cárcamo JM, Pedraza A, BÓrquez-Ojeda O, Golde DW. (2002). 
Vitamin C suppresses TNF alpha-induced NF kappa B activation 
by inhibiting I kappa B alpha phosphorylation. Biochemistry 41: 
12995-13002
Chanez P, Wenzel SE, Anderson GP, et al. (2007). Severe asthma 
in adults: what are the important questions? J Allergy Clin 
Immunol 119: 1337-1348 
Chang HH, Chen CS, Lin JY. (2009). High dose vitamin C 
supplementation increases the Th1/Th2 cytokine secretion ratio, 
but decreases eosinophilic infiltration in bronchoalveolar lavage 
fluid of ovalbumin-sensitized and challenged mice. J Agric Food 
Chem 57: 10471-10476
Cohn L, Tepper JS, Bottomly K. (1998). IL-4-independent induction 
of airway hyperresponsiveness by Th2, but not Th1, cells. J 
Immunol 161: 3813-3816
Desai D, Brightling C. (2009). Cytokine and anti-cytokine therapy in 
asthma: ready for the clinic? Clin Exp Immunol 158: 10-19 
Doherty T, Broide D. (2007). Cytokines and growth factors in airway 
remodeling in asthma. Curr Opin Immunol 19: 676-680 
 Du WD, Yuan ZR, Sun J, et al. (2003). Therapeutic efficacy of 
high-dose vitamin C on acute pancreatitis and its potential 
mechanisms. World J Gastroenterol 9: 2565-2569
Duan W, Chan JH, Wong CH, Leung BP, Wong WS. (2004). Anti-
inflammatory effects of mitogen-activated protein kinase kinase 
inhibitor U0126 in an asthma mouse model. J Immunol 172: 
7053-7059
Fogarty A, Lewis SA, Scrivener SL, et al. (2003). Oral magnesium and 
vitamin C supplements in asthma: a parallel group randomized 
placebo-controlled trial. Clin Exp Allergy 33: 1355-1359
Fogarty A, Lewis SA, Scrivener SL, et al. (2006). Corticosteroid 
sparing effects of vitamin C and magnesium in asthma: a 
randomised trial. Respir Med 100: 174-179 
Gao J, Gao X, Li W, Zhu Y, Thompson PJ. (2008). Obser  vational 
studies on the effect of dietary antioxidants on asthma: a meta-
analysis. Respirology 13: 528-536
 Guaiquil VH, Vera JC, Golde DW. (2001). Mechanism of vitamin Anat Cell Biol 43:294~302, 2010 Young-Joo Jeong, et al 302
www.acbjournal.com
www.acbjournal.org doi: 10.5115/acb.2010.43.4.294
allergy. Int Arch Allergy Immunol 124: 461-469
Noh K, Kim HG, Shin YA, et al. (2003). The effects of high-dose 
vitamin C administration on the cell-mediated immune response 
in mice. Immune Netw 3: 211-218
 Noh K, Lim H, Moon SK, et al. (2005). Mega-dose Vitamin 
C modulates T cell functions in Balb/c mice only when 
administered during T cell activation. Immunol Lett 98: 63-72
 Rizzo MR, Abbatecola AM, Barbieri M, et al. (2008). Evi  dence for 
anti-inflammatory effects of combined admini  stration of vitamin 
E and C in older persons with impaired fasting glucose: impact 
on insulin action. J Am Coll Nutr 27: 505-511
Sackesen C, Ercan H, Dizdar E, et al. (2008). A comprehensive 
evaluation of the enzymatic and nonenzymatic antioxidant 
systems in childhood asthma. J Allergy Clin Immunol 122: 78-
85
 Schock BC, Young IS, Brown V, Fitch PS, Shields MD, Ennis M. 
(2003). Antioxidants and oxidative stress in BAL fluid of atopic 
asthmatic children. Pediatr Res 53: 375-381
Scott DA, Poston RN, Wilson RF, Coward PY, Palmer RM. (2005). 
The influence of vitamin C on systemic markers of endothelial 
and inflammatory cell activation in smokers and non-smokers. 
Inflamm Res 54: 138-144
Tagaya E, Tamaoki J. (2007). Mechanisms of airway remodeling in 
asthma. Allergol Int 56: 331-340
Tecklenburg SL, Mickleborough TD, Fly AD, Bai Y, Stager JM. (2007). 
Ascorbic acid supplementation attenuates exercise-induced 
bronchoconstriction in patients with asthma. Respir Med 101: 
1770-1778
Tulic MK, Hamid Q. (2006). New insights into the pathophysiology 
of the small airways in asthma. Clin Chest Med 27: 41-52
Wannamethee SG, Lowe GD, Rumley A, Bruckdorfer KR, Whincup 
PH. (2006). Associations of vitamin C status, fruit and vegetable 
intakes, and markers of inflammation and hemostasis. Am J Clin 
Nutr 83: 567-574
Zhou J, Wolf CR, Henderson CJ, et al. (2008). Glutathione transferase 
P1: an endogenous inhibitor of allergic responses in a mouse 
model of asthma. Am J Respir Crit Care Med 178: 1202-1210